Cargando…
Epigenetic modifications: Critical participants of the PD-L1 regulatory mechanism in solid tumors (Review)
Immune checkpoint inhibitors targeting the programmed cell death protein 1 (PD-1)/programmed death ligand 1 (PD-L1) axis have achieved marked and durable efficacy in patients with different solid tumors and have improved their survival. However, the presence of primary or acquired resistance to immu...
Autores principales: | Ma, Xiaoran, Wu, Jibiao, Wang, Bin, Liu, Cun, Liu, Lijuan, Sun, Changgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521627/ https://www.ncbi.nlm.nih.gov/pubmed/36129152 http://dx.doi.org/10.3892/ijo.2022.5424 |
Ejemplares similares
-
Determination of Genetic and Epigenetic Modifications-Related Prognostic Biomarkers of Breast Cancer: Genome High-Throughput Data Analysis
por: Gao, Chundi, et al.
Publicado: (2021) -
Natural Polysaccharides and Their Derivates: A Promising Natural Adjuvant for Tumor Immunotherapy
por: Li, Ye, et al.
Publicado: (2021) -
ADRB1 was identified as a potential biomarker for breast cancer by the co-analysis of tumor mutational burden and immune infiltration
por: Wang, Jia, et al.
Publicado: (2020) -
Post-Translational Modifications of cGAS-STING: A Critical Switch for Immune Regulation
por: Yu, Yang, et al.
Publicado: (2022) -
Role of macrophages in tumor progression and therapy (Review)
por: Xu, Yiwei, et al.
Publicado: (2022)